Luuk J.J. Scheres

1.4k total citations
41 papers, 795 citations indexed

About

Luuk J.J. Scheres is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Luuk J.J. Scheres has authored 41 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Internal Medicine, 23 papers in Hematology and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Luuk J.J. Scheres's work include Blood Coagulation and Thrombosis Mechanisms (23 papers), Venous Thromboembolism Diagnosis and Management (23 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Luuk J.J. Scheres is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (23 papers), Venous Thromboembolism Diagnosis and Management (23 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Luuk J.J. Scheres collaborates with scholars based in Netherlands, United Kingdom and Germany. Luuk J.J. Scheres's co-authors include Saskia Middeldorp, Suzanne C. Cannegieter, Willem M. Lijfering, Eva N. Hamulyák, Mariëtte Goddijn, Ingrid M. Bistervels, Marjolein Brekelmans, Harry R. Büller, Paulien G. de Jong and Astrid van Hylckama Vlieg and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Luuk J.J. Scheres

39 papers receiving 764 citations

Peers

Countries citing papers authored by Luuk J.J. Scheres

Since Specialization

Citations

This map shows the geographic impact of Luuk J.J. Scheres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luuk J.J. Scheres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luuk J.J. Scheres more than expected).

Fields of papers citing papers by Luuk J.J. Scheres

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luuk J.J. Scheres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luuk J.J. Scheres. The network helps show where Luuk J.J. Scheres may publish in the future.

Co-authorship network of co-authors of Luuk J.J. Scheres

This figure shows the co-authorship network connecting the top 25 collaborators of Luuk J.J. Scheres. A scholar is included among the top collaborators of Luuk J.J. Scheres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luuk J.J. Scheres. Luuk J.J. Scheres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence, risk factors, and mortality of pulmonary embolism in the Netherlands (2015–22): sex differences and shifts during the coronavirus disease 2019 pandemic 2025 ·European Heart Journal ·Qingui Chen, Nienke van Rein, Luuk J.J. Scheres, (unknown), (unknown), Marieke J. H. A. Kruip, Suzanne C. Cannegieter	2
2	Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An International Open-Label, Randomised Controlled Trial 2024 ·Obstetrical & Gynecological Survey ·Siobhan Quenby, Katie Booth, Louise Hiller, Arri Coomarasamy, Paulien G. de Jong, Eva N. Hamulyák, Luuk J.J. Scheres, Thijs F. van Haaps, Lauren Ewington, Shreeya Tewary, Mariëtte Goddijn, Saskia Middeldorp	0
3	The fatty liver index and risk of incident venous thromboembolism: the Tromsø Study 2024 ·Research and Practice in Thrombosis and Haemostasis ·Luuk J.J. Scheres, Sigrid K. Brækkan, (unknown), Suzanne C. Cannegieter, John‐Bjarne Hansen, Vânia M. Morelli	1
4	Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial 2024 ·Research and Practice in Thrombosis and Haemostasis ·Eva N. Hamulyák, Hanke M.G. Wiegers, Barbara A. Hutten, (unknown), Anne Timmermans, Peter E. Westerweel, Marten R. Nijziel, Frederikus A. Klok, Marcel M.C. Hovens, Pieter W. Kamphuisen, Harry R. Büller, (unknown), Luuk J.J. Scheres	3
5	Hormone-related thrombosis: duration of anticoagulation, risk of recurrence, and the role of hypercoagulability testing 2024 ·Hematology ·Luuk J.J. Scheres, (unknown)	0
6	Time trends in antithrombotic therapy during pregnancy and maternal and perinatal outcomes in the Netherlands (2013–19): a nationwide cohort study 2024 ·The Lancet Haematology ·Qingui Chen, Nienke van Rein, Lisa Broeders, Saskia Middeldorp, Kitty W.M. Bloemenkamp, (unknown), Luuk J.J. Scheres	2
7	Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women 2024 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), J.F. Timp, Luuk J.J. Scheres, Linda E. Flinterman, Frans M. Helmerhorst, Frits R. Rosendaal, Suzanne C. Cannegieter, Astrid van Hylckama Vlieg	2
8	Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study 2023 ·SHILAP Revista de lepidopterología ·Eng Soo Yap, Willem M. Lijfering, J.F. Timp, Frits R. Rosendaal, Suzanne C. Cannegieter, Luuk J.J. Scheres	2
9	Sex‐specific aspects of venous thromboembolism: What is new and what is next? 2022 ·Research and Practice in Thrombosis and Haemostasis ·Luuk J.J. Scheres, Astrid van Hylckama Vlieg, Suzanne C. Cannegieter	18
10	Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome—What is the evidence? 2021 ·Journal of Thrombosis and Haemostasis ·Eva N. Hamulyák, Luuk J.J. Scheres, Mariëtte Goddijn, Saskia Middeldorp	20
11	Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study 2021 ·Journal of Thrombosis and Haemostasis ·Hanke M.G. Wiegers, Josien van Es, Ákos F. Pap, Anthonie W.A. Lensing, Saskia Middeldorp, Luuk J.J. Scheres	2
12	Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss 2020 ·Cochrane Database of Systematic Reviews ·Eva N. Hamulyák, Luuk J.J. Scheres, (unknown), Mariëtte Goddijn, Saskia Middeldorp	95
13	Cardiovascular risk prediction models for women in the general population: A systematic review 2019 ·PLoS ONE ·Sara J. Baart, Veerle Dam, Luuk J.J. Scheres, Johanna AAG Damen, René Spijker, Ewoud Schuit, Thomas P. A. Debray, Bart C.J.M. Fauser, Eric Boersma, Karel G.M. Moons, Yvonne T. van der Schouw	37
14	Endogenous sex hormones and risk of venous thromboembolism in young women 2019 ·Journal of Thrombosis and Haemostasis ·Luuk J.J. Scheres, Astrid van Hylckama Vlieg, Bart E.P.B. Ballieux, Bart C.J.M. Fauser, Frits R. Rosendaal, Saskia Middeldorp, Suzanne C. Cannegieter	18
15	Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis 2018 ·Thrombosis Research ·Alice Trinchero, Luuk J.J. Scheres, Jürgen H. Prochaska, Chiara Ambaglio, Philipp S. Wild, Saskia Middeldorp, Stavros Konstantinides, Stefano Barco	18
16	Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials 2018 ·Research and Practice in Thrombosis and Haemostasis ·Luuk J.J. Scheres, Willem M. Lijfering, Saskia Middeldorp, Y. Whitney Cheung, Stefano Barco, Suzanne C. Cannegieter, Michiel Coppens	10
17	Adults with osteogenesis imperfecta: Clinical characteristics of 151 patients with a focus on bisphosphonate use and bone density measurements 2018 ·Bone Reports ·Luuk J.J. Scheres, Fleur S. van Dijk, (unknown), (unknown), (unknown), Guus Janus, Anton Franken	12
18	Current and future burden of venous thrombosis: Not simply predictable 2018 ·Research and Practice in Thrombosis and Haemostasis ·Luuk J.J. Scheres, Willem M. Lijfering, Suzanne C. Cannegieter	65
19	Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin 2017 ·Thrombosis and Haemostasis ·Suzanne M. Bleker, Barbara A. Hutten, Anne Timmermans, Harry R. Büller, Saskia Middeldorp, Marjolein Brekelmans, Luuk J.J. Scheres	54
20	Bloodcurdling movies and measures of coagulation: Fear Factor crossover trial 2015 ·BMJ ·Banne Nemeth, Luuk J.J. Scheres, Willem M. Lijfering, Frits R. Rosendaal	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact